Eli Lilly and Co Newsroom

Eli Lilly Analyst Ratings

Benzinga01:12

Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $885 Price Target

Benzinga00:06

Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025

Futu NewsSep 16 15:31

JPMorgan raises the target price of Eli Lilly and Co to $1100

Gelonghui FinanceSep 14 13:56

BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101

Futu NewsSep 14 07:31

Correction: JP Morgan Maintains Overweight on Eli Lilly, Raises Price Target to $1100. Action Price Target Changed to Raises

BenzingaSep 14 00:40

Eli Lilly Is Maintained at Overweight by JP Morgan

Dow JonesSep 13 23:51

Bullish on the future of the "weight-loss miracle drug" Tesofensine, Citigroup reinitiates coverage of eli lilly and co (LLY.US) with a "buy" rating.

Zhitong FinanceSep 13 21:47

Eli Lilly Analyst Ratings

BenzingaSep 13 21:45

Citigroup Reinstates Buy on Eli Lilly, Announces $1060 Price Target

BenzingaSep 13 21:45

BofA Securities Initiates Eli Lilly and Co(LLY.US) With Buy Rating

Futu NewsSep 13 21:32

J.P. Morgan Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,100

Futu NewsSep 13 19:33

Citi Initiates Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $1,060

Futu NewsSep 13 17:31

Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating

Futu NewsSep 11 21:31

Eli Lilly Analyst Ratings

BenzingaSep 9 23:48

Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $885 Price Target

BenzingaSep 9 23:48

Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025

Futu NewsSep 9 16:32

TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050

Futu NewsSep 6 20:31

TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050

Futu NewsSep 6 05:31

Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating

Futu NewsSep 5 20:31